Drug Trial Radar · NCT01335412
Safety Surveillance After Immunization With IXIARO
Last checked: Nov 20, 2026Latest source record: Mar 10, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20,000
Actual
Start
Mar 2011
Primary completion
Jun 2013
Study completion Jun 2013
Sponsor
- Lead sponsor
- Valneva Austria GmbHIndustry
- Sponsor type
- Industry
- First posted
- Apr 14, 2011
Design
- Study type
- Observational
- Who can join
- All sexes, from 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an active electronic surveillance using data from the Defense Medical Surveillance System (DMSS) to detect and characterize serious, rare adverse events occurring within 42 days after vaccination with the Japanese Encephalitis Vaccine IXIARO within the US Military, to detect adverse events that occur more frequently after IXIARO and to electronically follow up pregnancies during or shortly before which IXIARO was administered. There will be no intervention and no individuals contacted.
Conditions
- Japanese Encephalitis
Interventions
Japanese Encephalitis Virus vaccine, inactivated, adsorbedBiological
2 x 6mcg / 0.5mL intramuscular injection, Day 0 and 28 (Primary series) or 1x 6mcg / 0.5mL intramuscular injection (Booster)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of pre-defined, serious adverse eventsTime frame: 42 days after each dose of IXIARO
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Military Vaccine Agency
Alexandria, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.